# Human Placental-Derived Stem Cell Transplantation

> **NCT01586455** · PHASE1 · COMPLETED · sponsor: **New York Medical College** · enrollment: 43 (actual)

## Conditions studied

- Mucopolysaccharidosis I
- Mucopolysaccharidosis VI
- Adrenoleukodystrophy
- Niemann-Pick Disease
- Metachromatic Leukodystrophy
- Wolman Disease
- Krabbe's Disease
- Gaucher's Disease
- Fucosidosis
- Batten Disease
- Severe Aplastic Anemia
- Diamond-Blackfan Anemia
- Amegakaryocytic Thrombocytopenia
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia

## Interventions

- **DRUG:** Human Placental Derived Stem Cell

## Key facts

- **NCT ID:** NCT01586455
- **Lead sponsor:** New York Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2020-06
- **Final completion:** 2022-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586455, "Human Placental-Derived Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01586455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*